| Last Action | to Judiciary (H) |
|---|---|
| Title | AN ACT relating to drugs. |
| Bill Documents |
Bill
|
| Impact Statements |
Corrections Impact
Local Mandate |
| Bill Request Number | 1490 |
| Sponsor | D. Floyd |
| Summary of Original Version | Amend KRS 217.015 to include products containing ephedrine, pseudoephedrine, and phenylpropanolamine as "legend drugs"; amend KRS 218A.1446 to allow the Office of Drug Control Policy to authorize use of the KASPER system for the required record keeping for ephedrine, pseudoephedrine, and phenylpropanolamine sales; amend KRS 217.215 to allow a pharmacist to dispense an ephedrine, pseudoephedrine, and phenylpropanolamine product without a prescription to a person evidencing physical symptoms treatable by those products; amend KRS 218A.202 to allow the KASPER system of prescription electronic reporting to accept data on sales of ephedrine, pseudoephedrine, and phenylpropanolamine products. |
| Index Headings of Original Version |
Local Mandate - Pseudoephedrine and related drugs, sale and dispensing of Corrections Impact - Pseudoephedrine and related drugs, sale and dispensing of Crimes and Punishments - Pseudoephedrine and related drugs, sale and dispensing of Criminal Procedure - Pseudoephedrine and related drugs, sale and dispensing of Drugs and Medicines - Pseudoephedrine and related drugs, sale and dispensing of Health and Medical Services - Pseudoephedrine and related drugs, sale and dispensing of Pharmacists - Pseudoephedrine and related drugs, sale and dispensing of Physicians and Practitioners - Pseudoephedrine and related drugs, sale and dispensing of Trade Practices and Retailing - Pseudoephedrine and related drugs, sale and dispensing of |
| 02/08/11 |
|
|---|---|
| 02/09/11 |
|
Last updated: 1/16/2019 3:43 PM (EST)